Skip to content

What is the immediate effect of a maximalist running shoe on the knee joint load of runners with patellofemoral pain?

The immediate effect of a maximal cushioning running shoe compared to a sham on patellofemoral joint force in runners with patellofemoral pain

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626001162303
Enrollment
90
Registered
2026-09-17
Start date
2026-10-03
Completion date
2027-12-03
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is a two-arm, single-blind, randomised, sham-controlled, parallel-group, superiority trial investigating the immediate effects of a maximal cushioning running shoe (Brooks Ghost Max 2) compared to a sham (Brooks Ghost 16) on patellofemoral joint force and clinical outcomes during running in individuals with patellofemoral pain. Participants will complete pre- and post-intervention biomechanical assessments in a single laboratory session.

Interventions

Arm 1 (maximal-cushioning running shoes) Participants randomised to this arm will complete the intervention running assessment in a black Brooks Ghost Max 2 maximal-cushioning running shoe. Before the intervention, participants will complete the baseline running assessment in a white Brooks Ghost 16 standardised neutral running shoe. For the baseline assessment, participants will first complete a 5-minute treadmill run in the white Brooks Ghost 16 at 3.0–3.5 m/s. This will be followed by two fa

Arm 1 (maximal-cushioning running shoes) Participants randomised to this arm will complete the intervention running assessment in a black Brooks Ghost Max 2 maximal-cushioning running shoe. Before the intervention, participants will complete the baseline running assessment in a white Brooks Ghost 16 standardised neutral running shoe. For the baseline assessment, participants will first complete a 5-minute treadmill run in the white Brooks Ghost 16 at 3.0–3.5 m/s. This will be followed by two familiarisation runs and eight acceptable 40-metre overground running trials at 3.0–3.5 m/s. Running speed will be measured using timing gates positioned around the force plates. Participants will walk back to the starting position between trials, with additional rest and water provided as needed. Perceived exertion will be measured after the complete set of running trials using the 6–20 Borg Rating of Perceived Exertion scale. After completing the baseline running assessment, participants will change into the black Brooks Ghost Max 2 and rest for 10 minutes before starting the post-running assessment. Participants will then complete a 5-minute treadmill familiarisation run at 3.0–3.5 m/s, followed by two familiarisation runs and eight acceptable 40-metre overground running trials at 3.0–3.5 m/s. The same running procedures, speed-monitoring method and rest arrangements used during the baseline assessment will be followed. Perceived exertion will again be measured after the complete set of running trials using the 6–20 Borg scale. The Brooks Ghost Max 2 is characterised by a high stack height, increased midsole volume, a mass of 298 g in a US men’s size 9, and pronounced rocker geometry. It is classified as a maximally cushioned neutral running shoe and does not incorporate motion-control or stability features. It scores 4/25 on the minimalist index, indicating a highly non-minimalist running shoe.

Sponsors

La Trobe University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

- Insidious onset of anterior or peripatellar knee pain, with a duration of at least 2 months. - Worst pain intensity equal or greater than 30 on a 0-100 numerical rating scale during the previous month. - Pain around or behind the patella during at least two of the following activities: sitting for a prolonged period, rising from sitting, squatting, kneeling, running, walking up stairs, walking down stairs, jumping, landing, heavy household activities and after sports and recreational activities. - Individuals who have maintained an average running volume of at least 5 km per week during the past 2 months. - Individuals must be able to understand and speak English.

Exclusion criteria

- History of knee surgery. - History of patellar dislocation. - Clinical evidence of meniscal injury or ligamentous instability. - Self-reported current or recent hip, ankle, or foot pain that could interfere with running biomechanics. - Use of any knee injection (e.g., PRP, hyaluronic acid, cortiscosteroid) in the previous 6 months - Pregnant.

Outcome results

None listed

Source: ANZCTR · Data processed: Sep 17, 2026